Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 31 05 2025
DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTE AU 31 MAI 2025 Article L.…
XRP News: XpFinance Surpasses 35 Percent Of Presale Allocation As The Bullish Momentum On $XRP Price Continues
VILNIUS, Lithuania, June 11, 2025 (GLOBE NEWSWIRE) — XpFinance, a decentralized lending and borrowing protocol on the XRP Ledger, announced…
Advanced Ceramics Market worth $16.27 billion by 2029, at 6.0%, says MarketsandMarkets™
Delray Beach, FL, June 11, 2025 (GLOBE NEWSWIRE) — In terms of value, the Advanced Ceramics Market is projected to reach…
Mattermost Names James Mullins as Vice President of Sales for EMEA and APAC
Proven sales leader brings over 30 years of technology sales experience to drive Mattermost’s global growth strategy James Mullins Mattermost…
Treatment.com AI Announces New Medical Education Suite to Enhance Clinical Skills Training Through AI-Simulated Patients
Updated AI-powered OSCE platform launched to enhance medical education delivery and evaluation. Successfully deployed at University of Minnesota with 240…
CREDIT AGRICOLE FINANCEMENT DE L’HABITAT SFH : EARLY REPURCHASE OF ISIN FR001400JLZ4
Montrouge, June 11, 2025 Crédit Agricole Financement de l’Habitat SFH ANNOUNCES EARLY REPURCHASE OF EUR 3,250,000,000 “obligations de financement de…
LEADING EDGE MATERIALS ANNOUNCES UP TO $4,000,000 NON-BROKERED PRIVATE PLACEMENT
LEADING EDGE MATERIALS ANNOUNCES UP TO C$4,000,000 NON-BROKERED PRIVATE PLACEMENT NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION…
Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders
Investment supports the development of first-in-class, non-addictive, non-hallucinogenic molecules with a non-synaptic target, differentiated from existing drugs First start-up company…
Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders
Delphine Charvin Delphine Charvin, CEO Elkedonia Proceeds to advance potentially disruptive, fast-acting therapeutics for treatment-resistant depression and other neuropsychiatric disorders…
IREN prices upsized $500 million convertible notes offering
SYDNEY, June 11, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (ACN 629 842 799) (“IREN”) today announced the pricing…
tpay Releases White Paper on the Transformative Power of Open Banking Across the Middle East
DUBAI, United Arab Emirates, June 11, 2025 (GLOBE NEWSWIRE) — tpay, the leading payment connector in the META region, has…
Persica strengthens global IP portfolio with EU patent granted for PP353
London, UK, 11 June 2025 – Persica Pharmaceuticals Limited (Persica), a clinical stage biotechnology company developing a transformative treatment for chronic…
↑